Trial in Progress: REL-NDV01-301 (BOOST) - A Phase 3, Randomized Study of Adjuvant Intravesical Sustained-Release Gemcitabine-Docetaxel (NDV-01) Versus Surveillance for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Trial in Progress: REL-NDV01-301 (BOOST) - A Phase 3, Randomized Study of Adjuvant Intravesical Sustained-Release Gemcitabine-Docetaxel (NDV-01) Versus Surveillance for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Sunday, May 17, 2026 9:56 AM to 10:04 AM · 8 min. (America/New_York)
Hall B, The Square, Learning Lab
Detail
Oncology: Prostate

Registered attendees

Boris Chertin
Boris Chertin
Chairman, The Department of Urology& Pediatric UrologyShaare Zedek Medical Center
Seth Lerner
Seth Lerner
Vice Chair for Faculty AffairsBaylor College of Medicine Scott Department of Urology

Log in

See all the content and easy-to-use features by logging in or registering!